Clinical trial
The Effects of TZD on Fat Metabolism and Insulin Sensitivity in GH-Replaced GHD…
NCT00459940 · University of Aarhus, Other · Completed
Key facts
| NCT number | NCT00459940 |
|---|---|
| Title | The Effects of TZD on Fat Metabolism and Insulin Sensitivity in GH-Replaced GHD Patients |
| Official title | "Can Growth Hormone's Lipolytic and Insulin-Antagonistic Effects be Modified by Peroxisome Proliferator-Activated Gamma Agonists?" |
| Lead sponsor | University of Aarhus, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Growth Hormone Deficiency |
| Intervention type | Drug |
| Interventions | Pioglitazone |
| Enrollment | 20 |
| Start date | Sep 1, 2004 |
| Completion | Mar 1, 2006 |
| First posted | Apr 13, 2007 |
| Last update posted | Apr 13, 2007 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: